483
Wuxi STA Pharmaceutical Co., LtdFDA 483 - Wuxi STA Pharmaceutical Co., Ltd - March 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of WuXi STA Pharmaceutical Co., LTD. in WuXi, China, revealed a significant quality control issue. The firm failed to perform routine calibrations of mechanical measuring instruments, including balances and sensors, according to its own written procedures and calibration plan. This lapse affects instruments used in the manufacturing process, indicating a potential risk to product quality.
Open in Dashboard
ID · ada6e1b2-a1f6-4eff-b151-0d16cc88a7a8